tirzepatide mixing chart reconstitution chart: complete and dosing reference Tirzepatide (Month 1) 2.5mg |

The FDA prescribing information for tirzepatide does not require tapering when discontinuing treatment

International Journal of Preventive Medicine [Internet]

Mounjaro (tirzepatide) is an injectable dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GIP/GLP1) agonist drug used in people with Type 2 diabetes

When you say yes to this journey, heres whats waiting for you: Carefully matched to the right therapy in 5 minutes or less

When to Consider a GLP-1 Consultation Consider scheduling a GLP-1 weight loss consultation if: You have tried multiple diets without lasting results Hunger or cravings make weight loss difficult You regain weight after losing it You have insulin resistance, prediabetes, or metabolic concerns You want physician supervision instead of a generic online program You are concerned about side effects and want proper monitoring You want to protect muscle while losing weight You live in Connecticut and want a local medical weight loss provider Contact Optimal Health Medical to schedule a GLP-1 weight loss consultation